TELA Bio, Inc.
TELA
$0.9596
-$0.0124-1.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.90% | 17.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.90% | 17.81% | |||
| Cost of Revenue | 5.48% | 21.96% | |||
| Gross Profit | -12.64% | 15.98% | |||
| SG&A Expenses | -12.94% | -0.81% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.19% | 2.39% | |||
| Operating Income | 10.80% | 19.06% | |||
| Income Before Tax | 9.83% | 17.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.22% | 17.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.22% | 17.68% | |||
| EBIT | 10.80% | 19.06% | |||
| EBITDA | 11.14% | 19.60% | |||
| EPS Basic | 45.27% | 17.81% | |||
| Normalized Basic EPS | 44.40% | 17.82% | |||
| EPS Diluted | 45.27% | 17.81% | |||
| Normalized Diluted EPS | 44.40% | 17.82% | |||
| Average Basic Shares Outstanding | 62.22% | 0.16% | |||
| Average Diluted Shares Outstanding | 62.22% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||